MEA INVESTMENT OPPORTUNITIES IN PHARMACEUTICALS: RISK/REWARD ANALYSIS

The Middle East & North Africa average in our Innovative Pharmaceuticals Risk/Reward Index (RRI) slightly underperforms the global average. The region is highly diverse, with a number of large Gulf States including Saudi Arabia, the UAE, and Kuwait scoring highly for access to, and demand for, innovative medicines. However, a number of significantly underdeveloped markets with low affordability levels, poor access to healthcare services and elevated industry-and country-specific risks drag the regional score below the global average.

Spotlight

FlowMetric, Inc

FlowMetric Inc is a specialized CRO partner providing state-of-the-art polychromatic flow cytometry experimental design , execution , analysis and aseptic cell sorting services. FlowMetric Inc provides preclinical through clinical development flow cytometry services.

OTHER WHITEPAPERS
news image

WILL PHARMA COMMIT TO DELIVERING AFFORDABLE THERAPEUTICS AGAINST COVID-19?

whitePaper | April 8, 2020

EPHA is a change agent – Europe’s leading NGO alliance advocating for better health. We are a dynamic member-led organisation, made up of public health civil society, patient groups, health professionals, and disease groups working together to improve health and strengthen the voice of public health in Europe.

Read More
news image

A BLOCKCHAIN TO ENSURE COUNTERFEIT FREE PHARMACEUTICAL SUPPLY CHAIN

whitePaper | February 5, 2022

Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains ensure that the right amount of medicine, with acceptable quality, will reach the customers in need

Read More
news image

Coronavirus (COVID-19) and Its Effect on Pharmaceutical Marketing and Sales

whitePaper | March 16, 2020

With the rapid onset of coronavirus in the United States, many pharma companies are being forced to prepare for a scenario in which their reps cannot visit providers and patients are limited in their ability to visit their healthcare professionals (HCP). The CDC has gone as far as recommending the use of telemedicine and patient portals as primary channels for HCPs and patients to interact.

Read More
news image

Paving the way for pharma R&D to use FAIR data

whitePaper | December 16, 2019

The use of FAIR (Findable, Accessible, Interoperable and Reusable) data in drug discovery and development could be transformational. But the pharma industry has been slow to embrace FAIR data — partially because of difficulties in establishing the necessary infrastructure and because of internal culture.

Read More
news image

Reimagining the pharma landscape with design thinking

whitePaper | July 29, 2021

As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.

Read More
news image

Defragmenting Data for the Future of Pharma R&D

whitePaper | November 7, 2019

This in-depth paper will show you how to become data agile – tackling both technological issues and solutions, and the cultural and strategic framework needed around this to ensure success.

Read More

Spotlight

FlowMetric, Inc

FlowMetric Inc is a specialized CRO partner providing state-of-the-art polychromatic flow cytometry experimental design , execution , analysis and aseptic cell sorting services. FlowMetric Inc provides preclinical through clinical development flow cytometry services.

Events